A Study of LY3493269 in Participants With Type 2 Diabetes
The main purpose of this study is to determine the side effects related to LY3493269 in participants with type 2 diabetes.
Trial Summary
Key Requirements
Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.Participants Must:
Participants must have type 2 diabetes that is under control, and HbA1c of at least 7.0% and no more than 10.5%
Participants must have stable body weight for the last three months
Participants must follow birth control requirements
Participants Must Not:
Participants must not have type 1 diabetes
Participants must not have uncontrolled diabetes (meaning that they required hospitalization for treatment of life-threatening complications of diabetes) in the last six months
Participants must not have had more than one episode of severe low blood sugar requiring emergency treatment within the last six months
Participants must not take blood sugar lowering drugs, other than a stable dose of metformin, within the last three months
Participants must not have other serious or unstable illnesses
Participants must not have undergone weight loss surgery (stomach stapling, lapbanding, etc.) or have taken prescription weight loss medicine within the last three months
Participants must not be pregnant or breastfeeding
Lilly Trial Alerts
You will complete the questionnaire on another website.YesNo